Stanford Cancer Institute Directory

Cancer Biology Profiles

Showing 21 - 30 of 42
    Professor of Pathology, of Genetics and, by courtesy, of Biology
    Associate Professor of Dermatology


    Peter Marinkovich, M.D., is an Associate Professor of Dermatology, a faculty member of the Program in Epithelial Biology and the Stanford Cancer Biology Program. He has an interest in inflammatory skin disease and is Director of the Stanford Bullous Disease and Psoriasis Clinics as well as an attending dermatologist at the VA Palo Alto Medical Center. Dr. Marinkovich’s research focuses on pathogenesis and therapy of epidermolysis bullosa, psoriasis, hair disorders and skin cancers.
    Mrs. George A. Winzer Professor in Cell Biology
    Rudy J. and Daphne Donohue Munzer Professor in the School of Medicine and Professor of Molecular and Cellular Physiology
    Eugene and Gloria Bauer Professor


    Anthony E. Oro, M.D., Ph.D., is a Professor of Dermatology and a member of the Program in Epithelial Biology, the Institute for Stem Cell Biology and Regenerative Medicine, Children’s Health Research Institute, Bio-X, and the Program in Cancer Biology.  His research interests encompass cancer genomics and tumor evolution, stem cell biology and hair/skin development and regeneration, and definitive molecular and cellular therapeutics.  His clinical interests include hair biology, non-melanoma skin cancer, and therapy for genetic skin diseases.
    Professor (Research) of Urology, Emerita
    Emma Pfeiffer Merner Professor in the Medical Sciences
    Professor of Radiology (General Radiology), of Biomedical Data Science and, by courtesy, of Management Science and Engineering
    Professor of Pathology
    Assistant Professor of Bioengineering and of Chemical and Systems Biology


    Dr. Lei (Stanley) Qi is an assistant professor in the Department of Bioengineering and Department of Chemical and Systems Biology at Stanford University. He is a faculty fellow in ChEM-H. He is one of the developers and pioneers in the CRISPR technology for sequence-specfic genome engineering. He has developed a series of CRISPR-based gene regulation and imaging technologies, including CRISPR interference (CRISPRi), CRISPR activation (CRISPRa), CRISPR imaging, and high-throughput CRISPRi/a screening. He works in the field of Synthetic Biology, and developed synthetic noncoding RNA approaches for control of the Central Dogma including ranscription and translation. He obtained his Ph.D. in Bioengineering from the University of California Berkeley in 2012, and performed independent research as a Systems Biology Fellow at UCSF from 2012 to 2014. His lab is currently applying genome engineering approaches for the interrogation of genomics related to cell differentiation, proliferation, epigenetic regulation and diseases.